Oncologist led cancer treatment centers in Nashville, Tennessee

Vanderbilt-Ingram Cancer Center, led by Dr. Puzanov Igor MD, is a renowned medical institution located at 2220 Pierce Avenue in Nashville, Tennessee, United States. Specializing in cancer care and treatment, the center offers cutting-edge medical services and personalized care to patients battling cancer. Dr. Puzanov Igor MD is a highly skilled and experienced doctor known for his expertise in oncology and dedication to improving the lives of cancer patients. With a focus on research, innovation, and compassionate care, Vanderbilt-Ingram Cancer Center is a leading institution in the fight against cancer.

Dr. Richard J. Geer, MD, FACS is a renowned institution located at 410 42nd Avenue North, Nashville, Tennessee, United States. Specializing in advanced breast surgery, complex GI and thyroid surgery, and surgical oncology, the institution is led by the retired but esteemed Physician-in-Chief, Dr. Richard Geer, who now refers his patients to Dr. Mark Cooper and Dr. Mariana Chavez. With a team of board-certified general surgeons, the institution offers a range of services including breast biopsy, breast cancer surgery, breast reconstruction, cancer surgery, and more. Operating Monday to Friday from 7:30am to 4:00pm, the institution is dedicated to providing top-notch healthcare services to its patients. Additionally, the institution provides insightful articles on various health topics such as bile duct cancer, GERD, and breast cancer on their website. Visit Dr. Richard J. Geer, MD, FACS for expert care in Nashville.

SCRI Oncology Partners is a leading institution located in Nashville, Tennessee, specializing in oncology research and treatment. Affiliated with the renowned Sarah Cannon Research Institute (SCRI), our team of internationally recognized experts have decades of experience in conducting clinical trials and providing personalized care for patients facing various types of cancer. From breast cancer to melanoma, our dedicated team offers access to the latest treatment options and innovative therapies, all within the comfort of the local community. Led by esteemed medical oncologists such as Dr. David R. Spigel and Dr. Erika P. Hamilton, SCRI Oncology Partners is committed to reducing inpatient hospital admissions and emergency department visits while offering state-of-the-art care and opportunities to participate in clinical trials with cutting-edge treatments. Our services include chemotherapy, immunotherapies, and next-generation sequencing, all aimed at advancing cancer care and improving patient outcomes.

Melissa Johnson, MD is a renowned institution located at 335 24th Avenue North in Nashville, Tennessee, United States. As part of SCRI Oncology Partners, they offer cutting-edge clinical trials in partnership with the prestigious Sarah Cannon Research Institute. With a focus on oncology research, Melissa Johnson, MD provides expert care for individuals facing various types of cancer, including breast, lung, melanoma, and more. Led by internationally recognized oncologists with years of experience, the institution is dedicated to bringing the latest treatment options to patients in their community. From chemotherapy to immunotherapies and clinical trials, Melissa Johnson, MD offers personalized care and innovative therapies to help individuals in their fight against cancer. To schedule an appointment or learn more, please contact them at 615-329-7640 or email cancercareSCRI@usoncology.com.

Meredith McKean, MD is a leading institution in Nashville, Tennessee, specializing in providing expert care for individuals facing cancer. Affiliated with SCRI Oncology Partners, the institution offers access to cutting-edge clinical trials through their partnership with Sarah Cannon Research Institute. With a team of internationally recognized experts with decades of experience, Meredith McKean, MD provides personalized care for various types of cancer, including breast, lung, melanoma, and more. Led by Dr. Meredith A. McKean, the institution is dedicated to bringing the latest treatment options to the community, reducing inpatient hospital admissions, and emergency department visits. Patients can expect state-of-the-art care, opportunities to participate in clinical trials, and innovative treatments such as chemotherapy, immunotherapies, and next-generation sequencing. For appointments or more information, contact 615-329-7640 or email cancercareSCRI@usoncology.com.

Vivek Subbiah, MD is a leading institution in Nashville, Tennessee, offering cutting-edge cancer care and clinical trials through their affiliation with Sarah Cannon Research Institute (SCRI). With a team of internationally recognized experts in oncology, SCRI Oncology Partners provides personalized care for a variety of cancers, including breast, lung, gastrointestinal, and more. Led by renowned oncologists such as Vivek Subbiah, MD, the institution focuses on bringing the latest treatment options and innovative therapies to the community, allowing patients to access advanced care close to home. With a strong emphasis on reducing hospital admissions and emergency department visits, SCRI Oncology Partners is dedicated to improving outcomes for those facing cancer. To learn more or schedule an appointment, contact the institution at 615-329-7640 or email cancercareSCRI@usoncology.com.

Denise Yardley, MD is a leading institution in Nashville, Tennessee, offering expert medical care in the field of oncology. As part of SCRI Oncology Partners, they conduct clinical trials through their affiliation with the renowned Sarah Cannon Research Institute. With a focus on bringing advanced science and innovative treatments to the community, the team at Denise Yardley, MD specializes in a wide range of cancer types including breast, lung, gastrointestinal, and more. Led by internationally recognized experts like Dr. Yardley, the institution provides personalized care, access to cutting-edge therapies, and opportunities to participate in clinical trials. Patients can rest assured that they are in good hands with the experienced team at Denise Yardley, MD. To schedule an appointment or learn more, contact them at 615-329-7640 or email cancercareSCRI@usoncology.com.

Meredith Pelster, MD is a part of SCRI Oncology Partners, a leading institution in oncology research located at 335 24th Avenue North, Nashville, Tennessee. With a focus on providing advanced cancer care and conducting clinical trials through their affiliation with Sarah Cannon Research Institute, SCRI Oncology Partners offers personalized treatment options for various types of cancer, including breast, lung, melanoma, and more. Led by internationally recognized experts like Meredith S. Pelster, MD, the institution is dedicated to bringing groundbreaking therapies to the community and reducing inpatient hospital admissions and emergency department visits. With a focus on chemotherapy, immunotherapies, and clinical trials, SCRI Oncology Partners is committed to providing the latest treatment options for individuals facing cancer. To schedule an appointment or learn more, contact them at 615-329-7640 or email cancercareSCRI@usoncology.com.

David Spigel, MD is a medical institution located at 335 24th Avenue North in Nashville, Tennessee, United States. As part of SCRI Oncology Partners, they conduct clinical trials in affiliation with Sarah Cannon Research Institute, a global leader in oncology research for over 30 years. The institution is dedicated to providing the latest treatment options for cancer patients in the community, offering specialized care in various areas including breast, gastrointestinal, lung, melanoma, and more. Led by internationally recognized experts such as Dr. David Spigel, Dr. Erika Hamilton, and Dr. Howard Burris, SCRI Oncology Partners provides personalized care, access to clinical trials, and innovative treatments. Patients facing cancer can receive top-notch care without having to travel far from home, with a focus on reducing hospital admissions and emergency department visits. To schedule an appointment or learn more, contact SCRI Oncology Partners at 615-329-7640 or email cancercareSCRI@usoncology.com.

Howard A. Skip Burris, III MD is a renowned institution located at 335 24th Avenue North in Nashville, Tennessee, United States. As part of SCRI Oncology Partners, they offer a wide range of clinical trials through their affiliation with Sarah Cannon Research Institute, a global leader in oncology research. With a team of internationally recognized experts with decades of experience, they provide specialized care for various types of cancer including breast, lung, gastrointestinal, and more. Patients at Howard A. Skip Burris, III MD have access to the latest treatment options and personalized care without having to travel far from home. Led by globally recognized oncologists such as Dr. Howard A. "Skip" Burris, III, they offer innovative treatments including chemotherapy, immunotherapies, and clinical trials. The institution aims to reduce inpatient hospital admissions and emergency department visits while providing groundbreaking therapies to the community.

Erika Hamilton, MD is a renowned institution located at 335 24th Avenue North in Nashville, Tennessee, United States. Specializing in oncology, Erika Hamilton, MD is affiliated with SCRI Oncology Partners, a global leader in cancer research with over 30 years of experience in managing clinical trials in the community. Led by internationally recognized experts such as Dr. Erika Hamilton, the institution offers personalized care and access to cutting-edge treatments for a wide range of cancers including breast, lung, melanoma, and more. Patients can benefit from clinical trials, chemotherapy, immunotherapies, and next-generation sequencing without having to travel far from home. With a focus on reducing inpatient hospital admissions and emergency department visits, SCRI Oncology Partners is dedicated to bringing groundbreaking therapies to the communities they serve. To schedule an appointment or inquire about their services, please contact 615-329-7640 or email cancercareSCRI@usoncology.com.

Ishwaria Subbiah, MD is a leading institution located at 335 24th Avenue North, Nashville, Tennessee, United States. Specializing in oncology, the institution is affiliated with SCRI Oncology Partners, a global leader in cancer research conducting clinical trials through their partnership with Sarah Cannon Research Institute (SCRI). With a focus on providing groundbreaking therapies and personalized care, the institution is dedicated to bringing the latest treatment options to the community. Led by internationally recognized experts such as Ishwaria M. Subbiah, MD, the institution offers care for a variety of cancer types including breast, gastrointestinal, genitourinary, gynecologic, lung, melanoma, and more. With a commitment to reducing inpatient hospital admissions and emergency department visits, the team at SCRI Oncology Partners strives to provide the best possible care for individuals facing cancer.

Benjamin Garmezy, MD is a leading medical institution located at 335 24th Avenue North, Nashville, Tennessee, United States. As part of SCRI Oncology Partners, they offer cutting-edge clinical trials in collaboration with Sarah Cannon Research Institute, a global leader in oncology research. With internationally recognized experts in various specialties, including breast, gastrointestinal, and lung cancers, they provide personalized care and access to innovative treatments to patients in the community. Led by renowned oncologists such as Dr. David R. Spigel and Dr. Erika P. Hamilton, the institution focuses on reducing inpatient hospital admissions and emergency department visits while offering advanced therapies like chemotherapy and immunotherapies. To schedule an appointment or learn more, contact them at 615-329-7640 or email cancercareSCRI@usoncology.com.